Related Experiment Video
Updated: Jul 7, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The role of proteases in transforming growth factor-beta activation
1University of Nottingham, Clinical Sciences Building, Nottingham City Hospital, Nottingham NG5 1PB, UK. gisli.jenkins@nottingham.ac.uk
Abstract:
Transforming growth factor-beta (TGFbeta) plays a central role in a number of developmental and pathological processes. There are 3 isoforms of TGFbeta (1-3) and all are sequestered in the extracellular matrix as latent complexes. Activation of this complex is the key biological checkpoint controlling TGF-beta bioavailability. This process is tightly regulated in a temporal, spatial and isoform specific manner highlighting its importance. There are many different mechanisms by which TGF-beta can be activated. Both serine and metalloproteinases play an important role in TGF-beta activation, at least in vitro, and many of these proteases have been implicated in pathological conditions. The mechanism of activation is distinct between the different proteases, but is not conserved between the two groups. Both serine proteases, such as plasmin, and metalloproteases, such as MMP2, can directly cleave latent TGFbeta, whereas others, such as thrombin and MMP14, interact with integrin mediated TGFbeta activation pathways. However, further studies are still required to fully understand the relevance of all of these pathways in vivo. Currently, the best described mechanism of TGF-beta1 activation in vivo is by integrins, although this process can be modulated by proteases. The primary mechanism of TGF-beta2 and TGF-beta3 activation has yet to be defined in vivo, although it is likely that TGF-beta3 is activated in a similar manner to TGF-beta1. This review describes the mechanism of protease driven TGF-beta activation, and discusses the physiological and pathological relevance of this process.
Insights
Transforming growth factor-beta (TGFbeta) activation is a key checkpoint in biological processes. Proteases like serine and metalloproteinases play distinct roles in releasing active TGFbeta, with integrins being crucial in vivo.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Transforming growth factor-beta (TGFbeta) is vital in development and disease.
- TGFbeta isoforms (1-3) are latent in extracellular matrix complexes.
- TGFbeta bioavailability is controlled by activation of these latent complexes.
Purpose of the Study:
- To review protease-driven TGFbeta activation mechanisms.
- To discuss the physiological and pathological relevance of TGFbeta activation.
- To highlight the distinct roles of serine and metalloproteinases in TGFbeta activation.
Main Methods:
- Review of existing literature on TGFbeta activation pathways.
- Analysis of protease mechanisms (serine and metalloproteinases) in TGFbeta activation.
- Comparison of in vitro and in vivo activation mechanisms.
Main Results:
- Serine proteases (e.g., plasmin) and metalloproteinases (e.g., MMP2) can directly cleave latent TGFbeta.
- Other proteases (e.g., thrombin, MMP14) utilize integrin-mediated pathways.
- Integrin-dependent activation is the best-described in vivo mechanism for TGFbeta1, modulated by proteases.
Conclusions:
- Protease mechanisms for TGFbeta activation differ between enzyme classes.
- Further in vivo studies are needed to clarify the roles of various proteases.
- The precise in vivo activation mechanisms for TGFbeta2 and TGFbeta3 require further investigation.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
Role of Matrix Metalloproteases in Degradation of ECM
A...
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins, also known...

